Synthesis, enantioseparation and pharmacological activity of 4-aryl-7,7-dimethyl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thiones

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 1, 2002, Pages 27-33

  Yarim, Mine ^a   Saraç, Selma ^a   Ertan, Mevlüt ^a   Kiliç, F Sultan ^a   Erol, Kevser ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

1,2,3,4,5,6,7,8 Octahydroquinazoline 2 thiones, calcium antagonist activity, enantioseparation, synthesis; Calcium antagonists

Indexed keywords

7,7 DIMETHYL 5 OXO 1,2,3,4,5,6,7,8 OCTAHYDROQUINAZOLINE 2 THIONE DERIVATIVE; ALDEHYDE; AMYLOSE; AROMATIC COMPOUND; CALCIUM ANTAGONIST; THIOUREA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CHIRALITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ILEUM; LAMB; NONHUMAN; RAT; REACTION ANALYSIS;

EID: 0036147996     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299852     Document Type: Article

References (27)

1. 100 Years of the biginelli dihydropyrimidine synthesis
2. Dihydropyrimidines: Novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity
3. Dihydropyrimidine calcium channel blockers. 2. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidine-carboxylic acid esters as potent mimics of dihydropyridines
4. Calcium entry blockers and activators: Conformational and structural determinants of dihydropyrimidine calcium channel modulators
5. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents
6. Dihydropyrimidine calcium channel blockers. 4. 3-Substituted-4-aryl-l,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents
7. Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,946
8. 4-Aryl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thione derivatives: Synthesis, enantiomeric separations and in vitro screening as calcium antagonist
9. Synthesis, chemical and pharmacological properties of some 4-aryl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-diones
10. 4-Aryl-6,6-dimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-diones: Synthesis, chromatographic resolution and pharmacological activity
11. Synthesis and in vitro calcium antagonist activity of 4-aryl-7,7-dimethyl/1,7,7-trimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2, 5-dione derivatives
12. Über aldehyduramide des acetessigäthers
13. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview
14. Useful chiral stationary phases for HPLC. Amylose tris(3,5-dimethyl-phenylcarbamate) and tris(3,5-dichlorophenylcarbamate) supported on silica gel
15. Tris(1-phenylethylcarbamate)s of cellulose and amylose as useful chiral stationary phases for chromatographic optical resolution
16. Resolution by high-performance liquid chromatography using polysaccharide carbamates and benzoates as chiral stationary phases
17. Planar chiral systems. I. Optical resolution of [2.2]paracyclophanes by high-performance liquid chromatography on tris-3,5-dimethyl-phenylcarbamates of cellulose and amylose
18. Kalzium-modulatoren vom Typ anellierter dihydropyridine/synthese und pharmakologische wirkung
19. 5-Oxo-1,4-dihydroindenopyridines. Calcium modulators with partial calcium agonistic activity
20. Synthesis and pharmacological activities of calcium modulatory hexahydroquinolinones
21. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine-dicarboxylate (Nisoldipine, Bay K 5552)
22. Synthesis of some 1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activity
23. Synthesis, configuration and calcium modulatory properties of enantiomerically pure 5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylates
24. 3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydroquinoline derivatives and their calcium antagonistic activities
25. Calcium antagonists: A class of drugs with a bright future. Part II. Determination of basic pharmacological properties